ReviewHead and neck pathology2026
Integrating Histological and Molecular Findings for Practical Salivary Gland Diagnostics.
Review in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this review paper is to provide an integrative algorithmic approach to the diagnosis of salivary gland tumors, including pertinent histologic features, immunohistochemical patterns and molecular driver mutations and/or fusions.
methodsReview of the literature was performed to provide an up-to-date synopsis of salivary gland tumors, in a concise and summarized format.
resultsDiagnostic workflow algorithms are created and included to complement the histomorphologic subgroups, to provide a user-friendly tool when approaching salivary gland tumors in routine surgical pathology.
conclusionHistomorphologic features and immunophenotype of majority of salivary gland tumors, including select molecular surrogate immunohistochemical stains, are the most important starting point in diagnostic interpretation. Molecular data can provide an additional data point for further supporting evidence and/or to aid in challenging cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.